1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,5-a]pyridine

Catalog No. :
ACBYFH975
CAS No. :
1416367-32-2
Molecular Formula :
C13H17BN2O2
Molecular Weight :
244.10

IUPAC Name:1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,5-a]pyridine

1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,5-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,5-a]pyridine
IUPAC Name1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,5-a]pyridine
Molecular FormulaC13H17BN2O2
Molecular Weight244.10
SMILESCC1(C)C(C)(C)OB(C2=C3C=CC=CN3C=N2)O1
InChI KeyGDDGFMPKVZSEFJ-UHFFFAOYSA-N
SynonymImidazo[1,5-a]pyridine, 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,5-a]pyridine
CAS No.1416367-32-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBYFH975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACDVHS875 route compound structure diagram
    ACDVHS8751422773-18-9 In Stock
  4. Then
  5. ACBYFH975 route product structure diagram
    ACBYFH9751416367-32-2
Inquiry

2. ACBYFH975 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFOBD029 route compound structure diagram
    ACFOBD029885275-80-9 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACBYFH975 route product structure diagram
    ACBYFH9751416367-32-2
Inquiry

Comments (0)